Linda Miller, RN Facebook ad: “Maintaining Internal Balance Beneath The Surface”

Started on November 1, 2026.
Run by Linda Miller, RN on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Make your own version of this ad
Crush makes it, launches it in your own Meta ad account, scales the winners and pauses the losers.
About this ad
- Meta Ad Library ID
- 1133169942931866
- Platforms
- Facebook, Instagram, Audience Network and Threads
- Relaunches
- 0
Ad text
My father could not open the register at his diner last Tuesday and I had to pretend I did not see it. He has been opening that register since 1983. It is the same brass NCR model my grandfather found at an estate sale in Concord and drove down to Charlotte in a pickup truck the week before my father opened Miller's on Central Avenue. It has a key that turns about a quarter inch and a drawer that pops out hard when it releases. You have to brace your other hand on the counter or it will knock into your hip. My father has opened that drawer ten thousand times. His name is Robert Miller. He is 71 years old. He has been running that diner for 41 years. He has hands that used to knead a double batch of biscuit dough without stopping, hands that carried a 50-pound flour bag on each shoulder up from the storage room without breaking stride. I watched him try the key twice. His fingers slid off it. He looked up, saw me watching, said the lock was sticky, and went into the back to check on the grits. I stood at the counter pretending to straighten the napkin holders. My name is Linda Miller. I am 61 years old. I live in Charlotte, North Carolina. I have been a registered nurse in neurology for 24 years. I have explained diabetic peripheral neuropathy to hundreds of families. I have drawn the diagram. I have watched people process what it means when a nerve conduction study tells them how far the damage has gone. I watched it happen to my own father for two years and found reasons not to act. That is what this is about. I want to back up. Because what I found, and what I am about to tell you, only makes sense if you understand what my father was like before, and what I had been doing with what I knew. My father has been a Type 2 diabetic for nine years. Diagnosed at 62 at a routine physical. His A1C came back at 7.4. His primary care doctor put him on Metformin and told him to watch his carbs and come back in three months. My father did everything he was told. He cut the sweet tea he had been drinking since childhood. He switched to whole grain bread in the diner kitchen and stopped eating his own biscuits. He walked 40 minutes every evening after he closed up. He took his Metformin twice a day without missing once. His A1C came down to 7.0 in the first year. Then 6.8. His doctor called the numbers managed. I am a neurology nurse. I have been drawing the diagram for 24 years. And I knew, even as my father's numbers improved on paper, that managed is not the same as protected. I knew the pathway. I have watched it in hundreds of patients. I said nothing. The things my father stopped doing happened gradually enough that I assigned each one its own separate reason. He stopped going up on the roof of the diner to clear the gutters. Said his shoulder. He stopped carrying the flour bags up from the storage room. Said his back. He started sitting on the stool behind the counter between customers. Said his hip. He dropped a plate one Thursday morning, a full breakfast plate, and looked at his right hand with an expression I have seen on patients and never once expected to see on him. He said the plate was wet. He went and got the mop. I am a neurology nurse of 24 years. Grip changes in a Type 2 diabetic man deserve investigation. They can have several causes, including neuropathic changes affecting fine motor control, or other complications of long-standing diabetes. I watched the signs accumulate over two years and I kept routing them to separate explanations rather than asking what might be connecting them. Then last Tuesday. The register. The key his fingers could not hold. The look he gave me before he said the lock was sticky. I drove home that evening and I sat at my kitchen table. James had already gone to bed. He is a history teacher and he wakes at five-thirty, and he had left a cup of tea on the counter for me the way he always does when I come home late, without being asked and without mentioning it. That is James. He makes my coffee before I come downstairs every morning too, has done it since we married, without a word about it either way. I sat at the kitchen table with the tea going cold and I opened my laptop and I started reading. Not as his daughter. As his nurse. Here is what I found. And what the gap between what I knew and what I applied had cost my father over nine years of managed numbers. This is established. In Type 2 diabetes, cells throughout the body become less responsive to insulin over time. One important part of that process involves a family of glucose transporter proteins called GLUT4. In a well-functioning response to a meal, rising insulin prompts GLUT4 transporters to move to the surface of muscle and fat cells, where they take up glucose from the blood. In the setting of insulin resistance, that signaling process is impaired. The efficiency of GLUT4 translocation is reduced. Less glucose is cleared from the blood after meals. Blood sugar stays elevated for longer. That persistent elevation matters in ways that accumulate over years. Chronically elevated blood glucose can damage small blood vessels throughout the body through a process called glycation, in which glucose molecules bind to proteins in vessel walls and progressively impair their structure. The capillaries that supply peripheral nerves, a network researchers call the vasa nervorum, are among the most vulnerable structures to this kind of damage. When those capillaries are compromised, the nerves they supply receive less oxygen and fewer nutrients. Nerve function can decline over time as a result. That is the established connection between poorly controlled blood glucose and peripheral nerve symptoms in diabetic patients. That is the diagram I have drawn hundreds of times. Grip changes in a long-standing diabetic man have more than one possible cause. But this pathway was a credible candidate. And I had been drawing the diagram for other people's fathers for 24 years without once sitting down with my own. Here is what Metformin does and does not do, stated accurately. Metformin's primary established mechanism is reducing how much glucose the liver produces and releases into the blood. That is a genuine and meaningful contribution to glucose management. It is not a complete answer to insulin resistance in peripheral tissues. GLUT4 translocation efficiency in muscle and fat cells can remain impaired even in patients on Metformin whose A1C reads well controlled. Blood glucose after meals may still stay elevated long enough to continue stressing the small vessels that supply peripheral nerves. This is a description of the medication's scope, not a criticism of it. Here is what is separately proposed, and proposed is the accurate word. A compound in true Ceylon cinnamon called MHCP has been studied in early-stage human research. The proposed mechanism is that MHCP may support the insulin signaling pathways involved in GLUT4 translocation, potentially improving how efficiently peripheral cells clear glucose from the blood after meals. Several small randomized trials have found reductions in fasting blood glucose and markers of insulin sensitivity in participants with Type 2 diabetes taking concentrated Ceylon cinnamon extract. Those are real studies. They are not large, long-term randomized controlled trials of the kind that establish clinical standards of care. The direct connection between improved glucose clearance and peripheral nerve function has not been established in controlled human trials. The mechanism is coherent. That is different from proven. What I read as a neurology nurse sitting at my kitchen table was a hypothesis aimed at the cellular glucose clearance side of the equation that my father's Metformin was not primarily addressing. Then I understood why every cinnamon supplement I had ever dismissed in clinical conversation was right to dismiss. Wrong species. Almost everything sold as cinnamon supplement in the United States, including in pharmacies and online, is cassia. Cinnamomum cassia. A different plant, grown primarily in China and Indonesia, not Sri Lanka. The research on GLUT4 activation and glucose management uses true Ceylon cinnamon, Cinnamomum verum. Cassia contains substantially less MHCP than true Ceylon. It also contains significantly higher concentrations of coumarin, a compound that can stress the liver at the sustained daily doses required to approach any meaningful effect. The supplements I had dismissively told patients to stop wasting money on were almost certainly cassia. My dismissal was correct. They were not what the research was studying. Wrong dose. Even genuine Ceylon cinnamon in standard retail form is typically sold as raw powder at a few hundred milligrams per serving. The human trials showing glucose effects used concentrated extracts. A 12 to 1 concentration delivers the raw-material equivalent of 7,200 milligrams of whole cinnamon per serving. Standard retail capsules deliver a fraction of that. Wrong delivery. The active compounds in true Ceylon cinnamon, including MHCP and cinnamaldehyde, are fat-soluble. They require a lipid carrier to be absorbed effectively through the gut wall. A dry powder capsule in an oil-free matrix does not provide that. Research on fat-soluble compound absorption consistently shows meaningful differences between oil-based and dry delivery formats. Three failure points simultaneously. Every standard cinnamon supplement fails at all three. The concept was not wrong. The execution was. The formula that addresses all three is called Metabolae. DNA-verified Cinnamomum verum from Sri Lanka. Concentrated 12 to 1 to deliver a 7,200 milligram raw equivalent per serving. Suspended in MCT oil from coconut to support absorption of the fat-soluble compounds. Coumarin-free. Third-party tested per batch. Non-GMO. Made in the USA in a GMP-certified facility. One softgel every morning with breakfast. Thirty softgels per bag, 30 days per bag. I ordered a bag from the official Metabolae website at 12:47 AM. Two days later I drove to my father's house after the lunch service. He was in his recliner watching a Braves game. I sat across from him and I told him what I had found. I told him I had been watching his grip change for two years and routing each sign to a separate explanation. I told him I wanted to address that pattern properly, starting with a conversation with his primary care doctor and a proper workup, and that alongside that I wanted to add something aimed at the cellular glucose clearance side of his management that his Metformin was not primarily addressing. I used the words a neurology nurse uses, not the words a daughter uses. He listened the way my father always listens, quietly and with his whole face. When I finished he said: 'You should have told me this years ago, Linda.' I did not have a good answer for that. We went to his primary care doctor the following week. I explained what I had observed and what I was concerned about. She agreed the grip changes warranted proper investigation. She ordered a nerve conduction study and a full metabolic panel. She had no objection to adding Metabolae alongside his existing medication while we waited for the workup. My father started taking one softgel every morning with his biscuit and his coffee. I want to tell you what the weeks that followed looked like. Week 1, nothing clinically meaningful. His grip felt the same to him. I told him to keep going. Week 2, his fasting glucose on his home meter began moving. He had been averaging 158 in the prior weeks. By the end of week 2 it was 143 on Monday, 136 on Thursday, 129 on Saturday. I noted it and said nothing to him yet. Week 3, my mother called me on a Wednesday afternoon. She said: 'Your father carried the flour bags up from the storage room this morning. Both of them.' I said: 'Mom. He has not done that since spring.' She said: 'I watched him do it. I did not say anything to him. I did not want to make it a thing.' That is my mother. Week 4, I ordered a second bag. Week 5, his fasting glucose was 109 on four consecutive mornings. I had not seen him below 120 in over two years. Week 6, I went to the diner on a Thursday morning before my hospital shift. My father was behind the counter working a full breakfast rush. I sat at the end stool with my coffee and I watched him. He carried a full tray to the corner booth without adjusting his grip once. He moved through the rush the way he used to move, without the pauses, without the compensations I had been watching him make for two years. I drank my coffee and did not say anything. Week 9, the nerve conduction study results came back. The study showed early-stage changes consistent with mild peripheral neuropathy in both feet, less severe than I had feared given the timeline. His primary care doctor said the findings gave her a baseline to track from and that she wanted to monitor annually. She was encouraged that his glucose environment had improved substantially in the interim. She reviewed his fasting log at that same appointment. She said: 'Robert. Your A1C is 6.2. It was 7.0 at your last visit. Your fasting glucose trend over the past month is consistently in the low one-teens. What changed.' My father looked at me. I told her. The late night reading. The GLUT4 translocation research. The proposed MHCP mechanism. The three failure points of standard cinnamon products. The distinction between early-stage research and established clinical evidence. What I had been watching in his hands for two years and calling management. She listened without interrupting. When I finished she said: 'Linda, you have been his daughter on this one for a long time.' I said: 'I know.' She said: 'Keep doing what you are doing and bring me the data at every visit. We will track his nerve function annually and watch his glucose environment carefully.' That is what a careful clinician says when she is watching numbers move in the right direction and wants to monitor responsibly. It is not a vindication. It is appropriate clinical engagement. That is exactly what should happen. Last Tuesday. The same day of the week that started all of this. I was at the diner at 7 AM. Slow morning. My father was setting up the register before the breakfast rush. I watched from the coffee station. He put the key in. He turned it. The drawer popped out hard the way it always has and he braced his other hand against the counter the way he used to brace it when I was a teenager watching him open the shop in the mornings. He counted the float. Set it in the tray. Closed the drawer. He looked up and saw me watching. He did not say the lock was sticky. He said: 'Good morning, Linda.' I said: 'Good morning, Dad.' I went and got my coffee. I am writing this because I drew the diagram of diabetic peripheral neuropathy for 24 years and never once drew it for my own father. Because I watched the signs accumulate over two years and assigned each one a separate reason. Because knowing the mechanism is not the same as applying it to the person in your own house. I am not telling you that what improved in my father's hands was caused by Metabolae. I cannot tell you that. I can tell you that his glucose environment improved substantially over the nine weeks he took it, that his primary care doctor was encouraged by the trend, that his nerve conduction study gave us a baseline that was less severe than I feared, and that the flour bags are coming up from the storage room again. You and his doctor will decide what to do with that. Metabolae. DNA-verified Cinnamomum verum from Sri Lanka. Concentrated 12 to 1 to deliver a 7,200 milligram raw equivalent per serving. Suspended in MCT oil from coconut to support absorption of the fat-soluble compounds. Coumarin-free. Third-party tested per batch. Non-GMO. Made in the USA in a GMP-certified facility. One softgel every morning with breakfast. Thirty softgels per bag, 30 days per bag. Metabolae is not sold on Amazon. It is not sold at Walmart. It is not available through any third-party marketplace. The cinnamon supplement market is full of mislabeled products. Cassia from China is routinely sold as Ceylon in packaging that looks identical at the point of purchase with no way to detect the substitution. The species, concentration, delivery format, and third-party testing can only be confirmed by ordering from the official Metabolae website. Metabolae comes in three options. One bag for a single month. Buy two bags and receive a third bag free. Buy three bags and receive two additional bags free with free shipping. Every order comes with a 90-day money-back guarantee. One softgel every morning with breakfast for 90 days. If his fasting glucose has not moved and you have seen no change, send back what is left in the bags and receive a full refund. No conditions. Opened bags accepted. Bring it to his doctor before he starts. Ask for a proper workup of any symptoms you are concerned about. Get a baseline. Track the data. That is how we did it. Not watching the number. Watching the hands. Order Metabolae today. ~ Linda P.S. My father is buying his own bags now. He does not tell me when he orders. I find out when he mentions he needs to reorder, and I ask how he is doing, and he says fine and changes the subject. Last week he carried both flour bags up from storage and the laundry basket from the back hallway in the same morning. My mother called to report both. She said it was probably a coincidence. I said probably. We left it there. Some things in my family do not need to be made into a thing. The register opens. That is enough. P.P.S. If you have a father like mine, do not wait until you watch him try the key twice and laugh it off. I watched the signs accumulate for two years and called each one something separate. I knew the mechanism. I drew the diagram for other people. I waited until the register. Do not wait as long as I waited. Take him to his doctor. Get a proper workup of what is changing. And ask whether the cellular side of his glucose management is being addressed alongside the number on the chart.
Where the ad sends people
metabolae.com
Maintaining Internal Balance Beneath The Surface
Supports healthy blood sugar levels and metabolism with premium Ceylon cinnamon. Shop Metabolae's science-backed supplements. Free shipping available.
Learn more: metabolae.com(opens in a new tab)










